VYNE Therapeutics Inc. - Common Stock, par value $0.0001 per share (VYNE)
CUSIP: 92941V308
Q3 2023 13F Holders as of 30 Sep 2023
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 18,514,484
- Total 13F shares
- 360,099
- Share change
- -8,341
- Total reported value
- $1,445,870
- Price per share
- $4.04
- Number of holders
- 20
- Value change
- -$33,734
- Number of buys
- 7
- Number of sells
- 8
Quarterly Holders Quick Answers
What is CUSIP 92941V308?
CUSIP 92941V308 identifies VYNE - VYNE Therapeutics Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 92941V308:
Top shareholders of VYNE - VYNE Therapeutics Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,935,057
|
$11,251,930 | — | 16 Aug 2021 | |
| DSC Advisors, L.P. |
13F
|
Company |
0.62%
|
115,000
|
$466,900 | — | 30 Jun 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.41%
|
76,380
|
$310,103 | — | 30 Jun 2023 | |
| Andrew Saik |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
116,468
|
$265,547 | — | 28 May 2021 | |
| Matthew T. Wiley |
3/4/5
|
Chief Commercial Officer |
—
class O/S missing
|
109,246
|
$249,081 | — | 30 Jun 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.27%
|
49,110
|
$201,351 | — | 30 Jun 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.24%
|
44,896
|
$184,073 | — | 30 Jun 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.19%
|
36,076
|
$148,000 | — | 30 Jun 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.13%
|
24,945
|
$101,276 | — | 30 Jun 2023 | |
| STALEY CAPITAL ADVISERS INC |
13F
|
Company |
—
class O/S missing
|
23,472
|
$96,235 | — | 30 Jun 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.06%
|
11,665
|
$47,360 | — | 30 Jun 2023 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.04%
|
7,520
|
$30,531 | — | 30 Jun 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
4,200
|
$17,220 | — | 30 Jun 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
2,210
|
$9,061 | — | 30 Jun 2023 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
1,392
|
$6,000 | — | 30 Jun 2023 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
1,086
|
$4,452 | — | 30 Jun 2023 | |
| MB, LEVIS & ASSOCIATES, LLC |
13F
|
Company |
0.01%
|
1,041
|
$4,268 | — | 30 Jun 2023 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0%
|
187
|
$759 | — | 30 Jun 2023 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0%
|
127
|
$521 | — | 30 Jun 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
89
|
$365 | — | 30 Jun 2023 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0%
|
22
|
$90 | — | 30 Jun 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
8
|
$32 | — | 30 Jun 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
6
|
$24 | — | 30 Jun 2023 | |
| Rex Bright |
3/4/5
|
Director |
—
class O/S missing
|
20,500
|
— | — | 19 Jul 2021 |
Institutional Holders of VYNE Therapeutics Inc. - Common Stock, par value $0.0001 per share (VYNE) as of Q3 2023
As of 30 Sep 2023,
VYNE Therapeutics Inc. - Common Stock, par value $0.0001 per share (VYNE) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
360,099 shares.
The largest 10 holders included
DSC Advisors, L.P., SUSQUEHANNA INTERNATIONAL GROUP, LLP, BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, US BANCORP \DE\, BANK OF AMERICA CORP /DE/, and Royal Bank of Canada.
This page lists
20
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
19
Q3 2023 holders
20
Holder diff
1
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 Value $ | Q3 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.